Cannabis 3.0 Accelerates Access to Consumer and Medical Research

Cannabis 3.0 Accelerates Access to Consumer and Medical Research

Authored By: Arundati Dandapani If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. Moreover over half of current cannabis users (52%) used apps on their mobile phone/tablet yesterday, with 66% reporting mobile app usage in the past week, and 74% reporting use in the past month, according to Vividata’s Spring Cannabis Consumer Study 2019. It is no surprise hence, given the relationship between cannabis users and heavy mobile app and internet use, that the cannabis industry is leveraging the next wave of technologies to fill knowledge gaps and accelerate awareness of research insights about consumers in adult-use cannabis and medical cannabis markets, in what is being referred to as Cannabis 3.0. A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Virtual Clinical Trials transcend geographic, mobility and economic barriers Clinical trials are medical research projects involving human participants. The main goals with conducting clinical studies, which could include observational studies or clinical trials, are to explore the causes of a disease or…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : Cannabis 3.0 Accelerates Access to Consumer and Medical Research
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.